QuantideX BCR-ABL US-IVD_650x210_monitor with confidenceReliable and clinically meaningful results you can trust

Assessing complete molecular response requires the highest possible assay sensitivity. The FDA cleared QuantideX® qPCR BCR-ABL IS Kit takes chronic myeloid leukemia (CML) monitoring to a new level of sensitivity at MR4.7 (0.002% IS). This unprecedented level of sensitivity enables you to detect loss of molecular response earlier and make patient management decisions armed with the best available diagnostic insights. By using a high precision assay that reports results on the International Scale, you can be confident that patient monitoring results are accurate and reproducible.

COMPLIANCE WITH GUIDELINES20160321SW_Asuragen_0032a

  • Direct reporting on the International Scale (IS)
  • Ability to assess Complete Molecular Response with an assay that has a sensitivity of MR4.7 (0.002%IS) determined using Human RNA dilutions

CONFIDENCE IN RESULTS

  • The first and only clinically validated, FDA cleared CML monitoring assay
  • High assay precision means the results don’t fluctuate from on time point to another

ASK YOUR LAB IF THEY ARE USING AN FDA CLEARED ASSAY


Please fill out the form below to request more information.

Back To
Top